Cirrhotic Liver Sustains In Situ Regeneration of Acellular Liver Scaffolds after Transplantation into G-CSF-Treated Animals

Cells. 2023 Mar 23;12(7):976. doi: 10.3390/cells12070976.

Abstract

Acellular liver scaffolds (ALS) produced by decellularization have been successfully explored for distinct regenerative purposes. To date, it is unknown whether transplanted ALSs are affected by cirrhotic livers, either becoming cirrhotic themselves or instead remaining as a robust template for healthy cell growth after transplantation into cirrhotic rats. Moreover, little is known about the clinical course of recipient cirrhotic livers after ALS transplantation. To address these questions, we transplanted ALSs into cirrhotic rats previously treated with the granulocyte colony-stimulating factor. Here, we report successful cellular engraftment within the transplanted ALSs at 7, 15, and 30 days after transplantation. Recellularization was orchestrated by liver tissue cell activation, resident hepatocytes and bile duct proliferation, and an immune response mediated by the granulocyte components. Furthermore, we showed that transplanted ALSs ensured a pro-regenerative and anti-inflammatory microenvironment, attracted vessels from the host cirrhotic tissue, and promoted progenitor cell recruitment. ALS transplantation induced cirrhotic liver regeneration and extracellular matrix remodeling. Moreover, the transplanted ALS sustained blood circulation and attenuated alterations in the ultrasonographic and biochemical parameters in cirrhotic rats. Taken together, our results confirm that transplanted ALSs are not affected by cirrhotic livers and remain a robust template for healthy cell growth and stimulated cirrhotic liver regeneration.

Keywords: G-CSF; decellularized extracellular matrix; decellularized liver; ductular reaction; in vivo recellularization; liver cirrhosis; liver fibrosis; liver regeneration; tissue engineering.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Granulocyte Colony-Stimulating Factor* / pharmacology
  • Hepatocytes / physiology
  • Liver Cirrhosis* / therapy
  • Rats
  • Tissue Scaffolds*

Substances

  • Granulocyte Colony-Stimulating Factor

Grants and funding

This study was supported by the National Center of Science and Technology for Regenerative Medicine/REGENERA grant No 465656/2014-5, National Research Council/CNPq grant No 406161/2018-6, Rio de Janeiro Research State Foundation/FAPERJ grant No E-26/211.266/2021 and Brazilian National Council for Scientific and Technological Development (CNPq) grant No 465656/2014-5 and CAPES/PROEX. During this study, the first author received “FAPERJ Nota 10 PhD scholarship (FAPERJ)” and CNPQ scholarship support.